John Greenwood

13PUBLICATIONS
83CO-AUTHORS
Gene and molecular therapyOptical technologyHaematological tumoursMedical devicesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 22, 2025
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice.

Giulia De Rossi, Ao-Wang Qiu, Maxime Berg

|Apr 25, 2025
LRG1 Alters Pericyte Phenotype and Compromises Vascular Maturation.

Alexandra E Hoeh, Jui-Hsien Chang, Ronja S Mueller

|Jun 10, 2022
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.

Clare Mills, Sandra A Hemkemeyer, Zerin Alimajstorovic

|Jun 01, 2022
Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential.

Javier Gutiérrez-Fernández, Faiza Javaid, Giulia De Rossi

|Mar 01, 2022
Correction: LRG1 as a novel therapeutic target in eye disease.

Giulia De Rossi, Marlene E Da Vitoria Lobo, John Greenwood

Pageof 3